Friday, October 18, 2019 3:50:15 PM
Recent ETON News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 08:19:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 10:30:14 AM
- Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen • GlobeNewswire Inc. • 10/03/2024 10:30:00 AM
- Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/22/2024 08:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:25:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:21:24 PM
- Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/08/2024 08:01:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/02/2024 08:16:27 PM
- Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 • GlobeNewswire Inc. • 07/30/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 08:16:01 PM
- Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution) • GlobeNewswire Inc. • 07/15/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:18:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:25:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:17:24 PM
- Eton Pharmaceuticals Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/09/2024 08:01:00 PM
- Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference • GlobeNewswire Inc. • 05/01/2024 08:05:00 PM
- Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution) • GlobeNewswire Inc. • 04/30/2024 11:00:00 AM
- Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 • GlobeNewswire Inc. • 04/29/2024 08:30:00 PM
- Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria • GlobeNewswire Inc. • 03/22/2024 06:00:00 AM
- Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/14/2024 08:01:00 PM
- Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024 • GlobeNewswire Inc. • 02/29/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 11:55:25 AM
- Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation • GlobeNewswire Inc. • 02/21/2024 11:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:21:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:19:59 PM
FEATURED Element79 Gold Corp Shares Further Advances With Chachas Community on Lucero Surface Rights, Provides Corporate Update • Oct 28, 2024 10:25 AM
VAYK Clarifies It Has No Business Connection to Persons Under SEC Charge • VAYK • Oct 28, 2024 11:59 AM
Vocodia Enters Medical Alert Industry with Innovative Emergency Response Pendant • VHAI • Oct 25, 2024 8:00 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for Third Quarter 2024 • HYDI • Oct 24, 2024 11:18 AM
VAYK Asserts Goal of Q4 Operationally Profitable and Projects Major 2025 Launch • VAYK • Oct 24, 2024 10:40 AM
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push • CBDL • Oct 24, 2024 7:07 AM